HomeProductsBioactive CompoundsSmall MoleculesRrx-001
Chemical structure of CAS 925206-65-1

Rrx-001

CAS No.925206-65-1
MDL No.MFCD25976849
MFC5H6BrN3O5
MW268.02
InChI KeyJODKFOVZURLVTG-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.925206-65-1
Product NameRrx-001

Associated Conditions

lymphoma·brain neoplasm·inflammation·anaplastic oligodendroglioma·colorectal neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.

Frontiers in oncology • Vol. 13 • 2023
PMID: 37313460PMC: PMC10258348DOI: 10.3389/fonc.2023.1204143

A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.

Drugs • Vol. 83, Issue 5 • 2023
PMID: 36920652PMC: PMC10015535DOI: 10.1007/s40265-023-01838-z

Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development.

Journal of medicinal chemistry • Vol. 64, Issue 11 • 2021
PMID: 34043360DOI: 10.1021/acs.jmedchem.1c00599

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Documentation